Market Overview

Morgan Stanley Offers Pre-2Q Thoughts on Monsanto Company

Related MON
Benzinga's M&A Chatter for Monday September 26, 2016
Benzinga's Top Upgrades
Ruane Cunniff Cuts Allergan, Berkshire, IBM (GuruFocus)

In a report published Thursday, Morgan Stanley analyst Vincent Andrews reiterated an Overweight rating and $150.00 price target on Monsanto Company (NYSE: MON).

In the report, Morgan Stanley noted, “F2Q buy side expectations appear below consensus but largely inline with our own due to a weather timing shift into F3Q. A modest bump to both the low and the high end of guidance is likely, but we do not anticipate a material guidance upgrade until F3Q reporting when all of the seed is planted.”

Monsanto Company closed on Wednesday at $111.72.

Latest Ratings for MON

Sep 2016BernsteinUpgradesUnderperformMarket Perform
Sep 2016JP MorganUpgradesNeutralOverweight
Sep 2016Deutsche BankMaintainsBuy

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Vincent AndrewsAnalyst Color Reiteration Analyst Ratings


Related Articles (MON)

View Comments and Join the Discussion!